DT388 GM-CSFAlternative Names: DT-GM; Truncated diptheria toxin-granulocyte-macrophage colony-stimulating factor
Latest Information Update: 26 Jul 2006
At a glance
- Originator Medical University of South Carolina; National Cancer Institute (USA); Terry Fox Laboratory
- Class Biological toxins; Granulocyte-macrophage colony-stimulating factors
- Mechanism of Action Immunosuppressants; Protein synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Acute myeloid leukaemia